Invention Grant
- Patent Title: Combination of cellular immunotherapy
-
Application No.: US16966789Application Date: 2019-02-02
-
Publication No.: US12178786B2Publication Date: 2024-12-31
- Inventor: Zonghai Li , Xiuqi Wu
- Applicant: CRAGE medical Co., Limited
- Applicant Address: HK Kowloon
- Assignee: CRAGE medical Co., Limited
- Current Assignee: CRAGE medical Co., Limited
- Current Assignee Address: HK Kowloon
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jill Gorny Sloper, Esq.
- Priority: CN201810107786.5 20180202,CN201810129611.4 20180208,CN201910008444.2 20190104
- International Application: PCT/CN2019/074535 WO 20190202
- International Announcement: WO2019/149279 WO 20190808
- Main IPC: A61P35/00
- IPC: A61P35/00 ; A61K31/4402 ; A61K38/17 ; A61K39/00 ; C07K16/28

Abstract:
Provided in the present invention is a method for treating tumor. An immune effector cell and a second treatment agent are applied to individual suffering from tumor, wherein the immune effector cell expresses a receptor for recognizing tumor antigen, and wherein the second treatment agent is a compound of formula I or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20210113614A1 COMBINATION OF CELLULAR IMMUNOTHERAPY Public/Granted day:2021-04-22
Information query
IPC分类:
A | 人类生活必需 |
A61 | 医学或兽医学;卫生学 |
A61P | 化合物或药物制剂的特定治疗活性 |
A61P35/00 | 抗肿瘤药 |